DRUG COSTS

Out of control—or delivering value?

Pharma innovation isn’t free—but few believe the sick should bear the costs. Balancing costs and benefits requires data, collaboration, and the courage to try new things.

Efficacy within reach

Is affordability a pipe dream?

As drugs become more sophisticated and targeted, they often become dramatically more expensive. Even common drugs can see massive price increases when patents change hands or new uses are found.

As our healthcare systems and patients bear the cost of pharmaceuticals, how do we create a system that is fair to all—especially those whose lives could be saved by greater availability of medications?

Read the article
Read the article
Read the article
Read the article
Article

NADAC-plus: An emerging paradigm in pharmacy pricing

LWith increased consumer and regulatory scrutiny on drug prices, stakeholders in the pharmacy supply chain are exploring drug pricing alternatives.

Download PDF
Products

Related Milliman products

Pharmaceutical claims analysis
Pharmaceutical claims analytics

MyRxConsultant

Compare contracted discount rates and savings with real-time pharmaceutical claims experience reporting.

ACA compliance and affordability
ACA compliance & affordability

Healthcare Reform Dashboard

Give small and mid-size employers essential analysis needed for ensuring compliance and plan affordability under the Affordable Care Act (ACA).

Healthcare analytics
Healthcare analytics

MedInsight

Adopt the healthcare industry’s leading platform for data warehousing and healthcare analytics.

Services

Related Milliman services

Product development and pricing: Healthcare

Medicare Part D

Pharmacy benefits consulting

Contact us

We’re here to help you break through complex challenges and achieve next-level success.